- Home
- CAI
as 11-05-2025 11:59am EST
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | IRVING |
| Market Cap: | 8.5B | IPO Year: | 2025 |
| Target Price: | $35.50 | AVG Volume (30 days): | 627.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -18.57 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.40 - $42.50 | Next Earning Date: | 11-05-2025 |
| Revenue: | $533,847,000 | Revenue Growth: | 106.53% |
| Revenue Growth (this year): | 64.66% | Revenue Growth (next year): | 45.81% |
Latest Caris Life Sciences Inc. Common Stock News
CAI Breaking Stock News: Dive into CAI Ticker-Specific Updates for Smart Investing
PR Newswire
22 days ago
Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025
Insider Monkey
a month ago
Caris Life Sciences, Inc. (CAI) Soars 81% YoY with $181M Q2 Revenue
Insider Monkey
2 months ago
Caris Life Sciences, Inc. (CAI) Secures FDA Nod for Revolutionary Tumor Profiling Test
Zacks
2 months ago
TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape
Compare CAI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CAI Caris Life Sciences Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.